Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary

RAD001 in Advanced Neuroendocrine Tumors, Fourth Trial (RADIANT-4) Study Group

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary'. Together they form a unique fingerprint.

Medicine & Life Sciences